Effects of Potassium Abnormalities on Cardiac Parameters
Both hyperkalemia and hypokalemia cause distinct ECG changes that can progress to life-threatening arrhythmias, but they have opposite effects on the QT interval and different impacts on heart rate, with minimal direct effects on blood pressure.
Hyperkalemia Effects
ECG/QTc Changes
Hyperkalemia produces progressive ECG changes that do not typically manifest until serum potassium exceeds 6.5 mmol/L 1. The characteristic sequence includes:
- Peaked T waves (5.5-6.5 mmol/L) - often the first indicator 2
- Prolonged PR interval (6.5-7.5 mmol/L) 1
- Widened QRS complex (7.0-8.0 mmol/L) 2, 1
- Flattened or absent P waves 2
- Sine-wave pattern, ventricular fibrillation, and asystole (>10 mmol/L) 1
Important caveat: The QTc interval is not prolonged in hyperkalemia—rather, the QRS widens while repolarization changes occur 1. Electrocardiographic manifestations vary among individuals and may not be predictable 1.
Heart Rate
Bradycardia may occur in severe hyperkalemia as a result of extremely prolonged PR and QRS intervals 1. This develops through progressive conduction system depression rather than direct sinus node effects.
Blood Pressure
The evidence does not describe significant direct blood pressure effects from acute hyperkalemia itself. However, hyperkalemia treatment with calcium can cause vasodilation and hypotension as a side effect 2.
Hypokalemia Effects
ECG/QTc Changes
Hypokalemia produces distinctly different ECG changes 1:
- Broadening/flattening of T waves 1
- ST-segment depression 1, 3
- Prominent U waves (most evident in V2-V3) 1, 3
- QT interval prolongation 3, 4
The QT prolongation in hypokalemia is particularly important because it increases risk for torsades de pointes, ventricular tachycardia, ventricular fibrillation, and cardiac arrest 1. In severe hypokalemia (<2.5 mEq/L), U-wave amplitude may exceed T-wave amplitude, though this may represent T-U wave fusion rather than true U-wave enlargement 5.
A 2025 study demonstrated statistically significant associations between severity of hypokalemia and prolonged QT interval (p=0.013), ST depression (p<0.001), T-wave flattening/inversion (p=0.007), and U waves (p<0.001) 3. Severe hypokalemia (<2.0 mEq/L) can produce QTc values exceeding 600-670 msec with associated ventricular arrhythmias 4.
Heart Rate
Hypokalemia does not consistently affect heart rate in a predictable direction 3. While various arrhythmias can occur (including first- or second-degree AV block, atrial fibrillation, PVCs), there is no characteristic bradycardia or tachycardia pattern. One study in anorexia patients with hypokalemia showed lower resting heart rates (55±11 vs 66±8 BPM), but this was attributed to increased vagal tone from the underlying condition rather than hypokalemia itself 4.
Blood Pressure
The evidence does not describe significant direct blood pressure effects from hypokalemia. The primary cardiovascular risk is arrhythmogenic rather than hemodynamic.
Clinical Implications
The most critical distinction: Hyperkalemia causes QRS widening and bradycardia through conduction system depression, while hypokalemia causes QT prolongation and predisposes to polymorphic ventricular tachycardia. Both can progress to cardiac arrest if untreated 2.
Key pitfall: ECG changes in hyperkalemia may not correlate reliably with serum potassium levels and can vary unpredictably among individuals 1. Never rely solely on ECG to exclude dangerous hyperkalemia.
For hypokalemia, ECG changes (particularly U waves, ST depression, T-wave changes, and QT prolongation) are reliable markers of severity and support ECG as a rapid bedside diagnostic tool 3. However, bolus potassium administration for cardiac arrest due to hypokalemia is ill-advised (Class III recommendation) 2.